Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
The Society of Nuclear Medicine and Molecular Imaging 2021 annual meeting wraps up this week. Look for continuing coverage of the latest research and developments from speakers and investigators.
For more SNMMI 2021 coverage, click here.
The conversation about the long-term impacts of head injuries sustained by football players has been swirling for decades. How they affect the brain and whether they lead to neurological dysfunction later in life are questions that have fueled a multitude of investigations. Later this week, look for an article based on a study that addresses this topic.
For more neurological imaging coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Women in radiation oncology are lagging behind in numbers compared to other specialties. Look for an article this week that discusses novel interventions detailed in Advances in Radiation Oncology that are designed to increase recruitment.
For more content on women in radiology, click here.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.